TRX — Tissue Regenix Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- £5.18m
- £12.00m
- $28.65m
Grant of share options
Posting of Annual Report & Notice of AGM
Final results for the year ended 31 December 2024
Brief: Tissue Regenix Group Terminates Strategic Review, No Longer In Offer Period
Conclusion of Strategic Review & Offer Period
Brief: Tissue Regenix Group Granted European Patent For Decellularisation Technology
Brief: Tissue Regenix Continues To Execute 4s Strategy
Company update
Brief: Tissue Regenix Group Sees Adj EBITDA Profit Above Expectations For Year
Full year trading update
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Brief: Tissue Regenix Extends Distribution Agreement With Arthrex
Extended distribution agreement with Arthrex, Inc.
Holding(s) in Company
Brief: Tissue Regenix Group Says No Indicative Non-Binding Proposals Received To Date
Response to media speculation
Brief: Tissue Regenix H1 Net Income USD -183 Thousand.